Xerri, Luc
Centre de Recherche en Cancérologie de Marseille,
France
2025 Rank: 97939
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 281 out of 25326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97939 | 106254 |
| Total Cites | 13385 | 15259 |
| H-index | 53 | 56 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 129 | 129 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 1002 | 1090 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 2086 | 2274 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11751 | 12980 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.18 |
| Self-Citation Percentage |
12.28%
|
|
Xerri, Luc
Institut Paoli-Calmettes,
France
2024 Rank: 95434
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 294 out of 24457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95434 | 103603 |
| Total Cites | 11845 | 13489 |
| H-index | 51 | 55 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 129 | 129 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 983 | 1069 |
| Number of Single+First+Last Authored Papers | 87 | 87 |
| Total Cites to Single+First+Last Authored Papers | 1983 | 2162 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10408 | 11493 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
12.19%
|
|
Xerri, Luc
Institut Paoli-Calmettes,
France
2023 Rank: 94181
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 290 out of 23576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94181 | 101040 |
| Total Cites | 10545 | 11992 |
| H-index | 49 | 52 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 128 | 128 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 965 | 1050 |
| Number of Single+First+Last Authored Papers | 86 | 86 |
| Total Cites to Single+First+Last Authored Papers | 1897 | 2070 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9310 | 10276 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
12.07%
|
|
Xerri, Luc
Institut Paoli-Calmettes,
France
2022 Rank: 90507
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 275 out of 23010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90507 | 95617 |
| Total Cites | 9740 | 11062 |
| H-index | 47 | 51 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 125 | 125 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 933 | 1016 |
| Number of Single+First+Last Authored Papers | 86 | 86 |
| Total Cites to Single+First+Last Authored Papers | 1823 | 1989 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8615 | 9504 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
11.95%
|
|
Xerri, Luc
Centre de Recherche en Cancerologie de Marseille,
France
2021 Rank: 86241
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 271 out of 22656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86241 | 95346 |
| Total Cites | 9347 | 10591 |
| H-index | 47 | 49 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 124 | 124 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 917 | 992 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 1780 | 1934 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8269 | 9112 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
11.75%
|
|
Xerri, Luc
Institut Paoli-Calmettes,
France
2020 Rank: 87240
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3657 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87240 | 92282 |
| Total Cites | 8356 | 9441 |
| H-index | 42 | 46 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 122 | 122 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 861 | 936 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 1654 | 1801 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7480 | 8228 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.15 |
| Self-Citation Percentage |
11.49%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.